Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that the U.S. Foodand DrugAdministration (FDA) has placed a ...
Results that may be inaccessible to you are currently showing.